Press Releases

Please click here if you wish to receive an e-mail notification regarding Alector press releases.

Jul 29, 2021
Alector Presents 12-Month Results from the INFRONT-2 Phase 2 Open-label Clinical Study of AL001 for the Treatment of Symptomatic Frontotemporal Dementia Patients with a Progranulin Mutation
Jul 21, 2021
Alector to Present New Data from Frontotemporal Dementia and Alzheimer’s Disease Programs at the 2021 Alzheimer’s Association International Conference
Jul 02, 2021
Alector and GSK announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseases
May 26, 2021
Alector to Host Virtual Key Opinion Leader Event on Frontotemporal Dementia on June 11, 2021
Displaying 1 - 10 of 14